| 001 | 838511 | ||
| 005 | 20231023125112.0 | ||
| 024 | 7 | _ | |2 Handle |a 2128/17599 |
| 037 | _ | _ | |a FZJ-2017-07103 |
| 100 | 1 | _ | |0 P:(DE-Juel1)132024 |a Strodel, Birgit |b 0 |e Corresponding author |
| 245 | _ | _ | |a Learning from simulations |
| 260 | _ | _ | |c 2017 |
| 336 | 7 | _ | |2 DataCite |a Text |
| 336 | 7 | _ | |0 PUB:(DE-HGF)4 |2 PUB:(DE-HGF) |a Communication |b comm |m comm |s 1520582817_31514 |
| 336 | 7 | _ | |2 BibTeX |a MISC |
| 336 | 7 | _ | |2 ORCID |a OTHER |
| 336 | 7 | _ | |2 DINI |a Other |
| 336 | 7 | _ | |0 4 |2 EndNote |a Personal Communication |
| 500 | _ | _ | |a Pan European Networks: Health 02: 91-92 |
| 520 | _ | _ | |a Alzheimer’s disease (AD) is the most common form ofdementia in the elderly. Currently, one in eight persons abovethe age of 65 is suffering from this disorder and it is expectedthat there will be 100 million persons affected by 2040. In AD, thesmall molecular weight amyloid-ß peptide (Aß) has been identifiedas a clinical hallmark in disease development and progression. |
| 536 | _ | _ | |0 G:(DE-HGF)POF3-553 |a 553 - Physical Basis of Diseases (POF3-553) |c POF3-553 |f POF III |x 0 |
| 856 | 4 | _ | |u http://edition.pagesuite-professional.co.uk/html5/reader/production/default.aspx?pubname=&edid=07dcafa0-b8b5-4a5d-b3d1-cbd8f366eeab |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/838511/files/PEN.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/838511/files/PEN.gif?subformat=icon |x icon |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/838511/files/PEN.jpg?subformat=icon-1440 |x icon-1440 |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/838511/files/PEN.jpg?subformat=icon-180 |x icon-180 |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/838511/files/PEN.jpg?subformat=icon-640 |x icon-640 |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/838511/files/PEN.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:838511 |p openaire |p open_access |p OpenAPC |p driver |p VDB |p openCost |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)132024 |a Forschungszentrum Jülich |b 0 |k FZJ |
| 913 | 1 | _ | |0 G:(DE-HGF)POF3-553 |1 G:(DE-HGF)POF3-550 |2 G:(DE-HGF)POF3-500 |3 G:(DE-HGF)POF3 |4 G:(DE-HGF)POF |a DE-HGF |b Key Technologies |l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |v Physical Basis of Diseases |x 0 |
| 914 | 1 | _ | |y 2017 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0510 |2 StatID |a OpenAccess |
| 920 | 1 | _ | |0 I:(DE-Juel1)ICS-6-20110106 |k ICS-6 |l Strukturbiochemie |x 0 |
| 980 | 1 | _ | |a APC |
| 980 | 1 | _ | |a FullTexts |
| 980 | _ | _ | |a comm |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a APC |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|